1
|
Yang L, Zhu Z, Qi Z, Fan X, Qian D, Zhang J, Duan J. Comparative Analysis of the Chemical Consistency Between the Traditional and Mixed Decoction of Maimendong Decoction by Ultra-Performance Liquid Chromatography Coupled to Quadrupole with Time-of-Flight Mass Spectrometry (UPLC-QTOF-MS)-Based Chemical Profiling Approach. J Chromatogr Sci 2020; 58:549-561. [PMID: 32378713 DOI: 10.1093/chromsci/bmz104] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Revised: 08/30/2019] [Accepted: 10/31/2019] [Indexed: 01/22/2023]
Abstract
Take Maimendong Decoction (MMDD), one of the Chinese classic herbal formulas, as an object to evaluate the chemical consistency between traditional decoction and mixed decoction. The ultra-performance liquid chromatography coupled to quadrupole with time-of-flight mass spectrometry-based chemical profiling approach has been utilized. A total of 48 major peaks are detected from these two decoctions under the present chromatographic and mass spectrometry conditions. The results of negative ion mode show nine significant inconsistencies. Liquiritin, ginsenoside Ro and ginsenoside Rg5/Rk1 are detected with higher intensity in traditional preparation sample than the mixed decoction, while licoisoflavone A is higher in mixed decoction samples than the traditional one. The mechanisms involved in the chemical changes were assumed to be anti-inflammation, anti-oxidative stress and so on, suggesting these two different preparation approaches of MMDD may lead to a possibility of discrepant clinical outcomes.
Collapse
Affiliation(s)
- Lan Yang
- School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Zhenhua Zhu
- Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.,Institute of Mental Health, Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu 215100, China
| | - Zhonghua Qi
- School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Xinsheng Fan
- School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Dawei Qian
- Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.,Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Jingjing Zhang
- Department of Respiratory, Nantong Hospital of Traditional Chinese Medicine, Nantong 226001, China
| | - JinAo Duan
- Jiangsu Key Laboratory for High Technology Research of Traditional Chinese Medicine Formulae Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.,Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
| |
Collapse
|
2
|
Soraoka H, Oniki K, Matsuda K, Ono T, Taharazako K, Uchiyashiki Y, Kamihashi R, Kita A, Takashima A, Nakagawa K, Yasui-Furukori N, Kadowaki D, Miyata K, Saruwatari J. The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers. Biol Pharm Bull 2017; 39:1468-74. [PMID: 27582327 DOI: 10.1248/bpb.b16-00248] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The concomitant use of herb and prescription medications is increasing globally. Herb-drug interactions are therefore a clinically important problem. Yokukansan (YKS), a Japanese traditional herbal medicine, is one of the most frequently used herbal medicines. It is effective for treating the behavioral and psychological symptoms of dementia. We investigated the potential effects of YKS on drug-metabolizing enzyme activities in humans. An open-label repeat-dose study was conducted in 26 healthy Japanese male volunteers (age: 22.7±2.3 years) with no history of smoking. An 8-h urine sample was collected after a 150-mg dose of caffeine and a 30-mg dose of dextromethorphan before and after the administration of YKS (2.5 g, twice a day for 1 week). The activities of cytochrome P450 (CYP) 1A2, CYP2D6, CYP3A, xanthine oxidase (XO) and N-acetyltransferase 2 (NAT2) were assessed based on the urinary metabolic indices of caffeine and dextromethorphan, and the urinary excretion ratio of 6β-hydroxycortisol to cortisol. There were no statistically significant differences in the activities of the examined enzymes before or after the 7-d administration of YKS. Although further studies assessing the influence of YKS on the pharmacokinetics and pharmacodynamics of the substrates of the drug-metabolizing enzymes are needed to verify the present results, YKS is unlikely that a pharmacokinetic interaction will occur with concomitantly administered medications that are predominantly metabolized by the CYP1A2, CYP2D6, CYP3A, XO and NAT2.
Collapse
Affiliation(s)
- Hiromi Soraoka
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Saruwatari J, Takashima A, Yoshida K, Soraoka H, Ding TB, Uchiyashiki Y, Tsuda Y, Imamura M, Oniki K, Miyata K, Nakagawa K. Effects of Seijo-bofu-to, a Traditional Japanese Herbal Medicine Containing Furanocoumarin Derivatives, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers. Basic Clin Pharmacol Toxicol 2014; 115:360-5. [DOI: 10.1111/bcpt.12224] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2013] [Accepted: 02/19/2014] [Indexed: 12/21/2022]
Affiliation(s)
- Junji Saruwatari
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Ayaka Takashima
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Kousuke Yoshida
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Hiromi Soraoka
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Tong-Bin Ding
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Yoshihiro Uchiyashiki
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Yoshiyuki Tsuda
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Motoki Imamura
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Kentaro Oniki
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| | - Keishi Miyata
- Department of Molecular Genetics; Graduate School of Medical Sciences; Kumamoto University; Kumamoto Japan
| | - Kazuko Nakagawa
- Division of Pharmacology and Therapeutics; Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
- Center for Clinical Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan
| |
Collapse
|
4
|
Saruwatari J, Takaishi C, Yoshida K, Takashima A, Fujimura Y, Umemoto Y, Abe T, Kitamado M, Shimomasuda M, Muramoto Y, Nakagawa K. A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers. J Pharm Pharmacol 2012; 64:670-6. [DOI: 10.1111/j.2042-7158.2011.01443.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Abstract
Objectives
Many patients use herbal medicines to relieve menopausal symptoms. Keishi-bukuryo-gan contains five herbal components, and has been used for treating hypermenorrhoea, dysmenorrhoea and menopausal symptoms in Asian countries. In this study, we investigated the potential herb–drug interactions of keishi-bukuryo-gan in healthy female subjects.
Methods
Thirty-one healthy females (20–27 years) were studied to evaluate their baseline activity of cytochrome P450 (CYP) 1A2, CYP2D6, CYP3A, xanthine oxidase (XO) and N-acetyltransferase 2 (NAT2) based on the urinary metabolic indices of an 8-h urine sample collected after a 150-mg dose of caffeine and a 30-mg dose of dextromethorphan, and also the urinary excretion ratio of 6β-hydroxycortisol to cortisol. Thereafter, the subjects received 3.75 g of keishi-bukuryo-gan twice daily for seven days, and underwent the same tests on post-dose day 7.
Key findings
The geometric mean phenotypic index for CYP1A2 significantly decreased by 16% on day 7 compared with the baseline (P = 0.026). Keishi-bukuryo-gan did not alter the indices for CYP2D6, CYP3A, XO and NAT2.
Conclusions
Keishi-bukuryo-gan may inhibit the activity of CYP1A2, which is predominantly involved in oestrogen metabolism. However, TJ-25 is unlikely to participate in herb–drug interactions involving medications predominantly metabolized by CYP2D6, CYP3A, XO and NAT2.
Collapse
Affiliation(s)
- Junji Saruwatari
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Chisato Takaishi
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Kousuke Yoshida
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Ayaka Takashima
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Youhei Fujimura
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Yuichiro Umemoto
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Tomohiro Abe
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Masataka Kitamado
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Masatsugu Shimomasuda
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Yousuke Muramoto
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
| | - Kazuko Nakagawa
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto, Japan
- Center for Clinical Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
| |
Collapse
|
5
|
Medicinal plants useful for treating chronic obstructive pulmonary disease (COPD): Current status and future perspectives. Fitoterapia 2011; 82:141-51. [DOI: 10.1016/j.fitote.2010.09.005] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2010] [Revised: 09/03/2010] [Accepted: 09/07/2010] [Indexed: 01/08/2023]
|
6
|
Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, Imazu Y, Reissenweber H, Witt CM. Traditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the Future. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE : ECAM 2011; 2011:513842. [PMID: 21687585 PMCID: PMC3114407 DOI: 10.1093/ecam/neq067] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/12/2009] [Accepted: 05/13/2010] [Indexed: 01/12/2023]
Abstract
The Japanese traditional herbal medicine, Kampo, has gradually reemerged and 148 different formulations (mainly herbal extracts) can be prescribed within the national health insurance system. The objective of this article is to introduce Kampo and to present information from previous clinical studies that tested Kampo formulae. In addition, suggestions on the design of future research will be stated. The literature search was based on a summary, up until January 2009, by the Japanese Society of Oriental Medicine and included only those trials which were also available in either Pubmed or ICHUSHI (Japan Medical Abstracts Society). We included 135 studies, half of these studies (n = 68) used a standard control and 28 a placebo control. Thirty-seven trials were published in English [all randomized controlled trials (RCTs)] and the remaining articles were in Japanese only. The sample size for most studies was small (two-third of the studies included less than 100 patients) and the overall methodological quality appeared to be low. None of the studies used Kampo diagnosis as the basis for the treatment. In order to evaluate Kampo as a whole treatment system, certain aspects should be taken into account while designing studies. RCTs are the appropriate study design to test efficacy or effectiveness; however, within the trial the treatment could be individualized according to the Kampo diagnosis. Kampo is a complex and individualized treatment with a long tradition, and it would be appropriate for further research on Kampo medicine to take this into account.
Collapse
Affiliation(s)
- Kenji Watanabe
- Center for Kampo Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Keiko Matsuura
- Center for Kampo Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Pengfei Gao
- Center for Kampo Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Lydia Hottenbacher
- Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, 10098 Berlin, Germany
| | - Hideaki Tokunaga
- Center for Kampo Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Ko Nishimura
- Center for Kampo Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Yoshihiro Imazu
- Center for Kampo Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
| | - Heidrun Reissenweber
- Research Unit for Japanese Phytotherapy (Kampo), Department of Internal Medicine, University of Munich, Munich, Germany
| | - Claudia M. Witt
- Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, 10098 Berlin, Germany
| |
Collapse
|
7
|
Uchi H, Tokunaga S, Mitoma C, Shibata S, Hamada N, Nakanishi Y, Kajiwara J, Yoshimura T, Furue M. A clinical trial of kampo formulae for the treatment of symptoms of yusho, a poisoning caused by dioxins and related organochlorine compounds. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2011; 2011:589724. [PMID: 19996156 PMCID: PMC3136710 DOI: 10.1093/ecam/nep209] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/29/2009] [Accepted: 11/12/2009] [Indexed: 11/29/2022]
Abstract
The objective of this study was to evaluate the effectiveness of traditional herbal medicines (Kampo) on the symptoms of Yusho. Yusho is a mass food poisoning that was caused by ingestion of rice oil contaminated with dioxins and related organochlorines in 1968. Patients with Yusho suffer from skin symptoms (acneform eruptions, liability to suppuration and pigmentation), respiratory symptoms (cough and expectoration of sputum), neurological symptoms (numbness and paresthesia of extremities), arthralgia and general fatigue, and no effective treatment has yet been developed. In this clinical trial, four Kampo formulae (Bakumondo-to, Keigai-rengyo-to, Gosha-jinki-gan and Hochu-ekki-to) were administered to four representative Yusho symptoms (respiratory, skin, neurological symptoms and general fatigue), respectively. Twenty-seven Yusho patients were enrolled and two formulae were administered to each patient for half-a-year each. The effectiveness of Kampo formulae was estimated by changes in the intensity of symptoms measured by a visual analogue scale (VAS) of 100 mm recorded at baseline and after administration of each formula. The influence of Kampo formulae on patients' quality of life (QOL) was also assessed by the SF-36 (NBS). Twenty-five patients completed the treatment. Bakumondo-to significantly improved respiratory symptoms as well as patients' QOL in the context of vitality, compared with other formulae. In contrast, Hochu-ekki-to impaired patients' QOL in the context of physical functioning and vitality, compared with other formulae. This study demonstrated for the first time that a Kampo formula Bakumondo-to is useful for treating respiratory symptoms caused by dioxins.
Collapse
Affiliation(s)
- Hiroshi Uchi
- Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka 812-8582, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Abstract
Herb-drug interactions are subject to much interest at present, but for various reasons reports may be unreliable or unsubstantiated. Herbal medicines are variable in composition and quality, which may affect their interaction profile as well as the reliability of reports concerning them. In this review, clinical and experimental reports have been collated, evaluated and summarised, and the theoretical and clinical evidence presented. There is an explanation of the particular issues involved with herbal medicines as compared with conventional drugs, and reasons why comparisons may or may not be valid, which is intended for those without specialist experience in herbal products. It has become apparent that only a few herbal drugs have so far been cited in interaction reports, for example St John's Wort, Ginkgo biloba, Dan Shen, liquorice, Ma huang and garlic, and that the main drugs involved are those which are already susceptible to interactions with many other conventional drugs, such as warfarin, protease inhibitors and anti-cancer drugs. An attempt has been made to put the matter into perspective and recommendations have been given for health professionals to advise or develop strategies to safeguard patients, without resorting to speculation or scaremongering.
Collapse
Affiliation(s)
- Elizabeth M Williamson
- The School of Pharmacy, University of Reading, PO Box 228, Whiteknights, Reading, Berkshire, RG6 6AJ, UK.
| |
Collapse
|